Volume 4, Issue 1, June 2020, Page: 30-33
Management for Priapism at the National Reference University Hospital Centers (NGRH) and at the Mother and Child Hospital (MCH) in Ndjamena
Mahamat Ali Mahamat, Department of Urology, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Kimassoum Rimtebaye, Department of Urology, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Clotaire Amkd Yameogo, Department of Urology, Yalgado Ouedraogo University Hospital, Ouagadougou, Burkina Faso
Moussa Kalli, Department of Urology, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Olivier Ngueringeum, Department of Pediatric Surgery, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Mahamat Nour Abakar, Department of Pediatric Surgery, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Medjine Tchiroue Arnaud, Department of Urology, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Oumar Atti, Department of Urology, Faculty of Health Sciences, University of N'Djamena, N'Djamena, Chad
Received: Mar. 5, 2020;       Accepted: Mar. 31, 2020;       Published: Apr. 17, 2020
DOI: 10.11648/j.ijcu.20200401.17      View  226      Downloads  59
Abstract
The authors studied therapeutic and evolutionary epidemiological, etiological and evolutionary traits. This is a review of patient records admitted to the surgical emergency departments of National Reference University Hospital Centers (NGRH) and at the Mother and Child University Hospital Centers (MCH) in Ndjamena with priapism that was taken care of from 2006 to 2016. Age, consultation time, etiology, established treatment and outcomes of management were the variables studied. The series involved 31 patients, the average age was 21. The main etiology was sickle cell priapism with 77% of cases. Six (6) patients or 19.3% had a history of prolonged erection. More than half of our patients (52%) had consulted after 72 hours of evolution. The puncture of cavernous bodies was the most widely used therapeutic method (45%). No major postoperative complications were recorded in the management of patients in our series. Sustained detumescence was achieved the same day or the next day in all our patients. Conclusion: Although priapism is rare in Africa, it is characterized by the predominance of sickle cell disease as etiology and the longtime of management in particular.
Keywords
Priapism, Drepanocytosis, Drainage Puncture, Cavernous Body, Chad
To cite this article
Mahamat Ali Mahamat, Kimassoum Rimtebaye, Clotaire Amkd Yameogo, Moussa Kalli, Olivier Ngueringeum, Mahamat Nour Abakar, Medjine Tchiroue Arnaud, Oumar Atti, Management for Priapism at the National Reference University Hospital Centers (NGRH) and at the Mother and Child Hospital (MCH) in Ndjamena, International Journal of Clinical Urology. Vol. 4, No. 1, 2020, pp. 30-33. doi: 10.11648/j.ijcu.20200401.17
Copyright
Copyright © 2020 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Reference
[1]
Broderick GA and al. Priapism: pathogenesis, epidemiology, and management. J Sex Med 2010; 7 (1pt2): 476-500.
[2]
Amadou. K and al. Clinical and therapeutic aspects of priapism at the Gabriel Touré University Hospital: study of 36 cases. Pan African Medical Journal. April 2014, 17: 286.
[3]
Bouya PA, Lomina D. Support for priapism in 32 cases at the Brazzaville University Hospital. Afr Noire's med. 2005August/Sept; 52 (5209): 453-55. PubMed (c) Google Scholar.
[4]
Oumarou H and al. Management of acute ischemic priapism at Niamey African Journal of Urology Lamordé National Hospital (2017) 23, 338-41.
[5]
Kamel K and al.: support of late-sighted low-flow priapism: about 28 cases. African Journal of Urology 2016, 22: 297-304.
[6]
Fall PA, Diao B, Ndoye AK, and al (2005) Priapism: clinical and etiological peculiarities. Afr J Urol 11: 186-90.
[7]
Falandry L: Priapism: treatment and results on a personal series of 56 cases. Prog. Urol, 1999, 9: 496-500.
[8]
Benchekroun A. Study of priapism on 16 cases. Annal urology. 1998; 2: 103- 106. PubMed (c) Google Scholar.
[9]
Virag R and al. Priapism about 172 cases. Annal of urology. 1997; 121: 642-52. PubMed (c) Google Scholar.
[10]
Adeyoju AB, Olujohungbe AB, Morris J, Yardumian A, BarefordD, Akenova A, and al. Priapism in sickle-cell disease; risk factors and complications — an international multicentrestudy. BJU Int 2002; 90 (9): 898—902.
[11]
C. Guillot-Tantay, Mr. Galiano. Priapism. EMC - AKOS (Medical Treaty) 2017; 12 (2): 1-4 [Article 1-0930].
[12]
Latoundji S, Ahlonsou G M, Anani L, Zohoun I. Priapism sickle cell disease in Benin. Afr Noire's med. 1992; 39 (2): 122-126. PubMed (c) Google Scholar.
[13]
LW Diggs. Pathology of Sickle Cell Disease. JAMA 1971; 218 (4): 600.
[14]
Musicki B, Karakus S, Akakpo W, Silva FH, Liu J, Chen H, et al. Testosterone replacement in transgenic sickle cell micecontrols priapic activity and upregulates PDE5 expression andeNOS activity in the penis. Andrology 2018; 6 (1): 184-91.
[15]
Fall B, Fall PA, Diao B, and al. Acute priapism associated with sickle cell disease in Senegal: clinical, therapeutic features and risk factors for erectile dysfunction. Med Too much. March 2010, 70: 475-8.
[16]
Kane R and al.: Support for priapism in Dakar in 35 cases. Andrology 2012, 22: 36-41.
[17]
Montague D. K and al. American Urological Association guideline on the management of priapism. J. Urol, 2003, 170: 1318-1324.
Browse journals by subject